How Has the Pregnyl Market Size Evolved in Recent Years?
The pregnyl market has seen considerable growth due to a variety of factors.
• In recent years, the market size of pregnyl has shown a considerable HCAGR of XX. The value of the market is anticipated to escalate from $XX million in 2024 to $XX million in 2025, reflecting a compound annual growth rate (CAGR) of XX%.
This notable development over the past years is due to factors such as the growing incidence of infertility, enhanced awareness about assisted reproductive technologies, an upward trend in adopting hCG-based treatments for hypogonadism, increased access to fertility clinics, encouraging government policies for reproductive health, and the swelling demand for treatments improving male fertility.
What are the Market Size and Expected Growth Rates for the Pregnyl Market?
The pregnyl market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the pregnyl market is projected to witness a significant increase, with XX (FCAGR). By 2029, the sector is predicted to expand to $XX million, representing a compound annual growth rate (CAGR) of XX%.
The boom in the market over the forecast period can be primarily associated with an increased rate in infertility, a rising requirement for assisted reproductive technologies, heightened awareness about hormonal disorders, and further accessibility to healthcare in emerging markets. In addition, the increase in pregnancies via hCG for male fertility treatments and an escalated healthcare spending also contribute to the upward trend. Notable advancements such as improvements in formulation, drug delivery systems, dosage accuracy, innovative combination treatments, incorporation of user-friendly packaging, and the implementation of telemedicine for distantly managing fertility are all set to be significant trends in the forecast period.
Which Key Drivers Are Propelling The Pregnyl Market's Growth?
The escalating instances of male hypogonadism are projected to contribute significantly to the expansion of the pregnyl market. Male hypogonadism is a disorder characterized by the body's insufficiency in producing testosterone, a pivotal hormone for male evolution and growth, or adequate sperm. Various contributing factors to its increased incidence include aging demographics, growing obesity rates, and exposure to environmental pollutants. Pregnyl effectively treats male hypogonadism by supplying human chorionic gonadotropin (hCG), which triggers the testes to generate testosterone and aids in spermatogenesis. This process regulates hormonal discrepancies, enhances testosterone concentrations, and revives fertility in hypogonadal men. For instance, statistics from the Endocrine Society, a non-profit organization based in the US, indicated in January 2022 that approximately 35% of men over the age of 45 and between 30-50% of men suffering from obesity or type 2 diabetes are affected by hypogonadism. Therefore, the escalating prevalence of male hypogonadism propels the progression of the pregnyl market.
What Are The Key Segments Within The Global Pregnyl Market?
The pregnyl market covered in this report is segmented –
1) By Indication: Fertility Treatments In Women, Male Infertility, Hypogonadotropic Hypogonadism
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End-User: Fertility Clinics, Research Institutions, Other End-Users
Pre-Book The Pregnyl Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Pregnyl Market?
Major companies operating in the pregnyl market are:
• Merck & Co.Inc.
What Are The Regional Insights Into The Pregnyl Market?
North America was the largest region in the pregnyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
